Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An image-based CRISPR screen reveals splicing-mediated control of HP1α condensates.

bioRxiv : the preprint server for biology·2026
Same author

CGE26-136: The Effects of Prostate Cancer Germline Genetic Testing on New and Existing Life Insurance Policies in California.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Case report: Metastatic pancreatic cancer to bilateral testes and spermatic cords.

Urology case reports·2026
Same author

CGE26-136: The Effects of Prostate Cancer Germline Genetic Testing on New and Existing Life Insurance Policies in California.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

The cognitive toll of household air pollution: cross-sectional associations between polluting cooking fuel use, cognitive functions and brain MRI in a rural aging population from Karnataka, India.

The Lancet regional health. Southeast Asia·2025
Same author

LiGeR-HN phase III trials of petosemtamab + pembrolizumab and petosemtamab monotherapy in recurrent or metastatic HNSCC.

Future oncology (London, England)·2025
Same journal

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Drug discovery today·2026
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
Same journal

Chemical intervention strategies targeting MYC for cancer therapy.

Drug discovery today·2026
Same journal

How many protein pairs can we chemically target?

Drug discovery today·2026
Same journal

From trial-and-error to inverse design: how AI is redefining drug delivery systems.

Drug discovery today·2026
Same journal

Critical evaluation of the key mediators causing life-threatening symptoms during human anaphylaxis.

Drug discovery today·2026
See all related articles

Related Experiment Video

Updated: May 24, 2026

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

Diving for drugs: tunicate anticancer compounds.

Edwin L Cooper1, David Yao

  • 1David Geffen School of Medicine at UCLA, University of California, Los Angeles, 90095-1763, USA. cooper@mednet.ucla.edu

Drug Discovery Today
|March 13, 2012
PubMed
Summary
This summary is machine-generated.

Marine tunicates offer unique compounds for cancer therapy. Ongoing research highlights their potential as novel anticancer drugs, with some already in clinical trials.

More Related Videos

Drug Screening of Primary Patient Derived Tumor Xenografts in Zebrafish
09:50

Drug Screening of Primary Patient Derived Tumor Xenografts in Zebrafish

Published on: April 10, 2020

Assay Development for High-Throughput Drug Screening Against Mycobacteria
07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Related Experiment Videos

Last Updated: May 24, 2026

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

Drug Screening of Primary Patient Derived Tumor Xenografts in Zebrafish
09:50

Drug Screening of Primary Patient Derived Tumor Xenografts in Zebrafish

Published on: April 10, 2020

Assay Development for High-Throughput Drug Screening Against Mycobacteria
07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Area of Science:

  • Marine biology
  • Pharmacology
  • Medicinal chemistry

Background:

  • The marine biosphere is a rich source of structurally unique secondary metabolites.
  • Bioprospecting in marine organisms, particularly tunicates, has yielded promising anticancer compounds.
  • Several marine-derived compounds are currently undergoing clinical trials for cancer treatment.

Purpose of the Study:

  • To discuss the potential of marine-derived compounds as anticancer drugs.
  • To highlight unique perspectives, compounds, and opportunities in marine bioprospecting for pharmaceuticals.
  • To review marine-derived antitumor drugs, their structures, and activities.

Main Methods:

  • Literature review of marine-derived antitumor compounds.
  • Analysis of compound structures and their mechanisms of action.
  • Evaluation of preclinical and clinical data on marine-derived anticancer agents.

Main Results:

  • Tunicates are a particularly successful source of anticancer drug leads.
  • Marine-derived compounds exhibit diverse structures and varying levels of antitumor activity.
  • Compounds from marine sources are progressing through clinical trials.

Conclusions:

  • Marine organisms, especially tunicates, represent a valuable resource for discovering novel anticancer drugs.
  • Further exploration of marine biodiversity is crucial for identifying potent and selective cancer therapies.
  • Marine-derived compounds hold significant promise for future cancer treatment strategies.